Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Ruiz

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Transplantation|June 7, 2003
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantationAndreas G Tzakis, Tomoaki Kato, Seigo Nishida, et al.
Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.
Annals of Surgery|August 25, 2007
Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantationTomoaki Kato, Andreas G Tzakis, Gennaro Selvaggi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 8, 2015
Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantationJeffrey J Gaynor, Gaetano Ciancio, Giselle Guerra, et al.
Transplantation|August 13, 2010
Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational studyGaetano Ciancio, Jeffrey J Gaynor, Junichiro Sageshima, et al.
The Journal of Clinical Investigation|April 19, 2014
Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosisJian-dong Zhang, Mehul B Patel, Robert Griffiths, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infectionGuy W Neff, Christopher B O'Brien, Jose Nery, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2009
A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertensionSteven D Crowley, Young-Soo Song, Gregory Sprung, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Direct Actions of AT<sub>1</sub> (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac HypertrophyMatthew A Sparks, Fitra Rianto, Edward Diaz, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 25, 2017
Meeting Report of the XIV International Small Bowel Transplant Symposium: Summary of Presentations, Workshops, and Debates From a Comprehensive Meeting on Intestinal Failure, Rehabilitation, and Transplantation, Buenos Aires, Argentina, June 10-13, 2015Gabriel E Gondolesi, Adriana Fernandez, Karolina M Burghardt, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Transplantation|June 7, 2003
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantationAndreas G Tzakis, Tomoaki Kato, Seigo Nishida, et al.
Plos One|August 26, 2016
CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab TreatmentRyuichi Hotta, Masahiro Ohira, Toshiharu Matsuura, et al.
Annals of Surgery|August 25, 2007
Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantationTomoaki Kato, Andreas G Tzakis, Gennaro Selvaggi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 8, 2015
Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantationJeffrey J Gaynor, Gaetano Ciancio, Giselle Guerra, et al.
Transplantation|August 13, 2010
Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational studyGaetano Ciancio, Jeffrey J Gaynor, Junichiro Sageshima, et al.
The Journal of Clinical Investigation|April 19, 2014
Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosisJian-dong Zhang, Mehul B Patel, Robert Griffiths, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2004
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infectionGuy W Neff, Christopher B O'Brien, Jose Nery, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2009
A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertensionSteven D Crowley, Young-Soo Song, Gregory Sprung, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Direct Actions of AT<sub>1</sub> (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac HypertrophyMatthew A Sparks, Fitra Rianto, Edward Diaz, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|April 25, 2017
Meeting Report of the XIV International Small Bowel Transplant Symposium: Summary of Presentations, Workshops, and Debates From a Comprehensive Meeting on Intestinal Failure, Rehabilitation, and Transplantation, Buenos Aires, Argentina, June 10-13, 2015Gabriel E Gondolesi, Adriana Fernandez, Karolina M Burghardt, et al.
Pageof 19